Page 1 | Search Results | Blood Advances | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity

Blood Adv (2024) 8 (12): 3314–3326.

https://doi.org/10.1182/bloodadvances.2024012637

Published: 2024

Includes: Supplemental data

Journal Articles

Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD

Blood Adv (2024) 8 (5): 1105–1115.

https://doi.org/10.1182/bloodadvances.2023011625

Published: 2024

Includes: Supplemental data

Journal Articles

Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy

Blood Adv (2021) 5 (21): 4465–4475.

https://doi.org/10.1182/bloodadvances.2021004716

Published: 2021

Includes: Supplemental data

Journal Articles

Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients

Blood Adv (2021) 5 (17): 3290–3302.

https://doi.org/10.1182/bloodadvances.2020003669

Published: 2021

Includes: Supplemental data

Journal Articles

Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia

Blood Adv (2021) 5 (16): 3147–3151.

https://doi.org/10.1182/bloodadvances.2021004234

Published: 2021

Includes: Supplemental data

Journal Articles

Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma

Blood Adv (2021) 5 (1): 143–155.

https://doi.org/10.1182/bloodadvances.2020002732

Published: 2021

Includes: Supplemental data

Journal Articles

Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma

Wen-Kai Weng, Sally Arai, Andrew Rezvani, Laura Johnston, Robert Lowsky, David Miklos, Judith Shizuru, Lori Muffly, Everett Meyer, Robert S. Negrin, Erica Wang, Timothy Almazan, Lynn Million, Michael Khodadoust, Shufeng Li, Richard T. Hoppe, Youn H. Kim

Blood Adv (2020) 4 (18): 4474–4482.

https://doi.org/10.1182/bloodadvances.2020001627

Published: 2020

Journal Articles

Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort

Michael A. Spinner, Vanessa E. Kennedy, John S. Tamaresis, Philip W. Lavori, Sally Arai, Laura J. Johnston, Everett H. Meyer, David B. Miklos, Lori S. Muffly, Robert S. Negrin, Andrew R. Rezvani, Judith A. Shizuru, Wen-Kai Weng, Richard T. Hoppe, Samuel Strober, Robert Lowsky

Blood Adv (2019) 3 (16): 2454–2464.

https://doi.org/10.1182/bloodadvances.2019000297

Published: 2019

Includes: Supplemental data

Journal Articles

Allogeneic transplantation using TLI-ATG conditioning for Hodgkin lymphoma after failure of autologous transplantation

Michael A. Spinner, Ranjana H. Advani, Richard T. Hoppe, Robert Lowsky, Lori S. Muffly

Blood Adv (2018) 2 (13): 1547–1550.

https://doi.org/10.1182/bloodadvances.2018021071

Published: 2018

Journal Articles

Infusion of donor-derived CD8 + memory T cells for relapse following allogeneic hematopoietic cell transplantation

Lori Muffly, Kevin Sheehan, Randall Armstrong, Kent Jensen, Keri Tate, Andrew R. Rezvani, David Miklos, Sally Arai, Judith Shizuru, Laura Johnston, Everett Meyer, Wen-Kai Weng, Ginna G. Laport, Robert S. Negrin, Sam Strober, Robert Lowsky

Blood Adv (2018) 2 (6): 681–690.

https://doi.org/10.1182/bloodadvances.2017012104

Published: 2018

Journal Articles

HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity

Michael A. Spinner, Marcelo Fernández-Viña, Lisa E. Creary, Olivia Quinn, Linda Elder, Sally Arai, Laura J. Johnston, Everett H. Meyer, David B. Miklos, Lori S. Muffly, Robert S. Negrin, Judith A. Shizuru, Wen-Kai Weng, Ginna G. Laport, Samuel Strober, Robert Lowsky, Andrew R. Rezvani

Blood Adv (2017) 1 (17): 1347–1357.

https://doi.org/10.1182/bloodadvances.2017007716

Published: 2017

Includes: Supplemental data

NARROW

CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity

Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD

Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy

Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients

Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia

Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma

Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma

Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort

Allogeneic transplantation using TLI-ATG conditioning for Hodgkin lymphoma after failure of autologous transplantation

Infusion of donor-derived CD8 + memory T cells for relapse following allogeneic hematopoietic cell transplantation

HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only